Vaxdyn's mission is to reduce the global impact on public health of infections caused by antibiotic-resistant bacteria. The proposal of Vaxdyn is to fight these infections by the patient's own immune system. The company is developing vaccine candidates against the most urgent threats by using an unique and proprietary platform. In 8 years, the people at risk will be vaccinated with Vaxdyn's products, brought to the market by the big pharma.